FCP OP MEDICAL BioHealth Trends FCP OP ... - Sal. Oppenheim
FCP OP MEDICAL BioHealth Trends FCP OP ... - Sal. Oppenheim
FCP OP MEDICAL BioHealth Trends FCP OP ... - Sal. Oppenheim
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
HEALTHCARE MARKET<br />
Pharmaceutical industry – transforming the business model<br />
40<br />
35<br />
30<br />
25<br />
20<br />
15<br />
10<br />
5<br />
0<br />
10<br />
18<br />
EXPECTED PATENT EXPIRIES IN THE PHARMACEUTICAL INDUSTRY<br />
iin USD bbn � Situation: Declining sales as a result of expired<br />
37<br />
patents, therapy substitution and a lack of research<br />
efficiency<br />
29<br />
23<br />
20<br />
17<br />
16<br />
14 14 14<br />
2005 2006 2007 2008 2009 2010 2011e 2012e 2013e 2014e 2015e 2016e<br />
Source: Medical Strategy GmbH, IMS, FDA, Bernstein Research As of: 2011<br />
13<br />
� TTransformation: f ti<br />
› Mega-mergers (Pfizer/Wyeth)<br />
› Transformation into bio-pharmaceutical companies<br />
(Roche/Genentech)<br />
› Diversification by adding speciality pharma<br />
(Novartis/Alcon) and medtech (Abbott/Advanced<br />
Medical Optics)<br />
› Expansion in emerging markets<br />
Patent expiries p have a negative g impact p on future development p<br />
06/30/2012| Page 12 <strong>Oppenheim</strong> Asset Management Services S.à r.l.
Change language